- CEO
- Sunil Siddharth Lalbhai
- Full Time Employees
- 6,323
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Address
- Atul Valsad GU India 396020
- IPO Date
- Nov 15, 1994
- Business
- Atul Ltd, founded in 1947 and headquartered in Atul, Gujarat, India, manufactures and markets a broad portfolio of specialty chemicals, operating as one of India's largest integrated chemical companies with production facilities in Gujarat and Maharashtra, as well as subsidiaries in the United States, United Kingdom, United Arab Emirates, China, and Brazil; it serves over 4,000 customers across more than 30 industries in 90 countries. The company produces over 900 products and 400 formulations, organized into two main segments—Life Science Chemicals and Performance and Other Chemicals—encompassing organic intermediates such as para-cresol and para-anisic aldehyde; polymers and resins including epoxy phenol novolac and resorcinol formaldehyde; dyes and pigments like Vat Green 1, Pigment Red 168, and sulphur black; agrochemicals comprising 2,4-D, indoxacarb, and propoxur; and pharmaceutical active pharmaceutical ingredients such as acyclovir, fluconazole, and valacyclovir. Recent developments include the formation of a 50:50 joint venture with Buckman Laboratories (Asia) Pte. Ltd. in August 2025 named Atul-Buckman to manufacture and market advanced water treatment solutions in India and Sri Lanka; the commissioning of a 1,035 crore caustic-chlorine plant at its Atul facility in January 2024; the expansion of liquid epoxy resin capacity to 80,000 tons per annum completed in October 2024; the launch of a new patented post-emergence herbicide in 2024; and the inauguration of a 200-bed NABH-compliant multi-specialty hospital by Atul Healthcare in Pardi, Gujarat, in February 2025.